rabeprazole and pantoprazole
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Gastroesophageal Reflux
Conditions
Gastroesophageal Reflux
Trial Timeline
— → Apr 1, 2005
NCT ID
NCT00237367About rabeprazole and pantoprazole
rabeprazole and pantoprazole is a approved stage product being developed by Eisai for Gastroesophageal Reflux. The current trial status is completed. This product is registered under clinical trial identifier NCT00237367. Target conditions include Gastroesophageal Reflux.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00237367 | Approved | Completed |
Competing Products
20 competing products in Gastroesophageal Reflux